Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study

医学 内科学 危险系数 结直肠癌 肿瘤科 癌胚抗原 比例危险模型 置信区间 化疗 前瞻性队列研究 癌症 胃肠病学
作者
Jean–Baptiste Bachet,Pierre Laurent‐Puig,Aurélia Meurisse,Olivier Bouché,Léo Mas,Valérie Taly,Romain Cohen,Jean‐Marc Gornet,Pascal Artru,Samy Louafi,Anne Thirot‐Bidault,Isabelle Baumgaertner,Romain Coriat,David Tougeron,Thierry Lecomte,Florence Mary,Thomas Aparicio,Lysiane Marthey,Hélène Blons,Déwi Vernerey,Julien Taı̈eb
出处
期刊:European Journal of Cancer [Elsevier BV]
卷期号:189: 112934-112934 被引量:2
标识
DOI:10.1016/j.ejca.2023.05.022
摘要

Baseline circulating tumour DNA (ctDNA) is a potential prognostic marker in metastatic colorectal cancer (mCRC) patients. However, few studies have compared ctDNA with the usual prognostic factors, and no ctDNA cut-off has been proposed for daily use in clinical practice.Chemotherapy-naive patients with mCRC were prospectively included. Plasma samples were collected at diagnosis and analysed centrally by both NGS and methylation digital PCR. Baseline patient and disease characteristics, treatment regimens, and secondary surgeries were collected. The restricted cubic spline method was used to define the optimal cut-off of ctDNA mutated allelic frequency (MAF). Prognostic values were assessed on overall survival (OS) using Cox models.From July 2015 to December 2016, 412 patients were included. ctDNA was undetectable in 83 patients (20%). ctDNA was an independent prognostic marker for OS considering the whole study population. The optimal cut-off for ctDNA MAF was 20% with median OS of 16.0 and 35.8 months for patients with MAF ≥20% and<20%, respectively (hazard ratio = 0.40; 95% confidence intervals: 0.31-0.51; P < 0.0001). The independent prognostic value of ctDNA MAF at 20% was confirmed in subgroups defined by RAS/BRAF status or resectability of metastases. Combining ctDNA MAF and carcinoembryonic antigen levels allowed us to define three different prognostic groups with median OS of 14.2, 21.1, and 46.4 months (P < 0.0001).ctDNA with a MAF cut-off of 20% improves prognostication of chemotherapy-naïve mCRC patients and may be useful in the future for individualised therapeutic decisions and as a stratification factor in clinical trials.Clinicaltrials.gov, NCT02502656.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
hang发布了新的文献求助10
1秒前
2秒前
dwct发布了新的文献求助10
2秒前
weifeng发布了新的文献求助10
2秒前
2秒前
lubo完成签到,获得积分10
2秒前
2秒前
爰采唐矣发布了新的文献求助10
2秒前
3秒前
3秒前
善学以致用应助小芭乐采纳,获得10
3秒前
拂晓发布了新的文献求助10
3秒前
SciGPT应助feihua采纳,获得10
4秒前
4秒前
4秒前
dongdong发布了新的文献求助10
5秒前
5秒前
sdl发布了新的文献求助10
5秒前
5秒前
沉静丹寒发布了新的文献求助10
6秒前
泽丶完成签到,获得积分10
6秒前
AI_S发布了新的文献求助10
6秒前
情怀应助周常通采纳,获得10
7秒前
知栀完成签到 ,获得积分10
8秒前
lubo发布了新的文献求助10
8秒前
8秒前
SUN发布了新的文献求助10
8秒前
8秒前
8秒前
大个应助石贵远采纳,获得10
8秒前
九点半上课了完成签到,获得积分10
9秒前
hang完成签到,获得积分10
10秒前
10秒前
12秒前
dwct完成签到,获得积分10
12秒前
12秒前
Mxs发布了新的文献求助10
13秒前
丘比特应助TOMORI酱采纳,获得10
13秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974943
求助须知:如何正确求助?哪些是违规求助? 3519467
关于积分的说明 11198482
捐赠科研通 3255728
什么是DOI,文献DOI怎么找? 1797904
邀请新用户注册赠送积分活动 877261
科研通“疑难数据库(出版商)”最低求助积分说明 806224